Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. Estimating global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019; 144 (8): 1941â53.
Olorunfemi G, Ndlovu N, Masukume G, Chikandiwa A, Pisa PT, Singh E. Temporal trends in cervical cancer epidemiology in South Africa (1994-2012). Int J Cancer. 2018; 143 (9): 2238â49.
Sengayi-Muchengeti M, Joko-Fru WY, Miranda-Filho A, Egue M, Akele-Akpo MT, N’da G, et al. Survival of cervical cancer in sub-Saharan Africa by age, stage at diagnosis, and human development index: a population-based registry study. Int J Cancer. 2020.
Battista RN, Grover SA. Early detection of cancer: an overview. Annu Rev Public Health. 1988; 9: 21-45.
Adanu RM. Knowledge and screening of cervical cancer in Accra, Ghana. J Women’s Health Gend Based Med. 2002; 11 (6): 487-8.
Nassali MN, Tadele M, Nkuba RM, Modimowame J, Enyeribe I, Katse E. Predictors of locally advanced disease in presentation and clinical outcome in patients with cervical cancer admitted to hospital tertiary sector in Botswana. Int J Gynecol Cancer. 2018; 28 (6): 1218â25.
Dunyo P, Effah K, Udofia EA. Factors associated with late presentation of cervical cancer cases in a district hospital: a retrospective study. BMC Public Health. 2018; 18 (1): 1156.
Force USPST, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Cervical Cancer Screening: Recommendation Statement from the US Prevention Services Task Force. JAMA. 2018; 320 (7): 674â86.
Priest P, Sadler L, Sykes P, Marshall R, Peters J, Crengle S. Determinants of inequalities in cervical cancer stage at diagnosis and survival in New Zealand. Control of the causes of cancer. 2010; 21 (2): 209-14.
Brewer N, Pearce N, Jeffreys M, Borman B, Ellison-Loschmann L. Does History of Screening Explain Ethnic Stage Differences in Cervical Cancer Diagnosis in New Zealand? Int J Epidemiol. 2010; 39 (1): 156-65.
Gyenwali D, Pariyar J, Onta SR. Factors associated with late diagnosis of cervical cancer in Nepal. Asian Pac J Cancer Prev. 2013; 14 (7): 4373-7.
Berraho M, Obtel M, Bendahhou K, Zidouh A, Errihani H, Benider A, et al. Sociodemographic factors and delay in the diagnosis of cervical cancer in Morocco. Pan Afr Med J. 2012; 12:14.
Mwaka AD, Garimoi CO, Were EM, Roland M, Wabinga H, Lyratzopoulos G. Social, demographic and health factors associated with stage at diagnosis of cervical cancer: a cross-sectional study in a tertiary hospital in northern France Uganda. BMJ Open. 2016; 6 (1): e007690.
SEER N. Cancer Stat Facts: Breast Cancer 2017[Availableat:https://seercancergov/statfacts/html/breast-subtypeshtml[Availablefrom:https://seercancergov/statfacts/html/breast-subtypeshtml[Disponiblesur:https://seercancergov/statfacts/html/breast-subtypeshtml[Availablefrom:https://seercancergov/statfacts/html/breast-subtypeshtml
Ibrahim A, Rasch V, Pukkala E, Aro AR. The predictors of cervical cancer are at an advanced stage at the time of diagnosis in Sudan. Int J Women’s Health. 2011; 3: 385-9.
Stewart TS, Moodley J, Walter FM. Population risk factors for late stage cervical cancer presentation in sub-Saharan Africa. Epidemiol of cancer. 2018; 53: 81-92.
Saghari S, Ghamsary M, Marie-Mitchell A, Oda K, Morgan JW. Sociodemographic predictors of late-stage versus early-stage cervical cancer in California. Anne EpidÃ©miol. 2015; 25 (4): 250-5.
Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. Clinical and demographic predictors of advanced cervical cancer. Arch Fam Med. 2000; 9 (5): 439â45.
Begoihn M, Mathewos A, Aynalem A, Wondemagegnehu T, Moelle U, Gizaw M, et al. Cervical cancer in Ethiopia: predictors of advanced stage and extended time to diagnosis. Infect the cancerous agent. 2019; 14:36.
Anakwenze C, Bhatia R, Rate W, Bakwenabatsile L, Ngoni K, Rayne S, et al. Factors related to the advanced stage of cancer presentation in Botswana. J Glob Oncol. 2018; 4: 1-9.
Mwaka AD, Okello ES, Orach CG. Barriers to biomedical care and the use of traditional medicines for the treatment of cervical cancer: an exploratory qualitative study in northern Uganda. Eur J Cancer Care (Eng). 2015; 24 (4): 503-13.
Botswana National Cancer Registry. http://afcrn.org/membership/members/118-bncr.
Johnson LG, Ramogola-Masire D, Teitelman AM, Jemmott JB, Buttenheim AM. To assess nurses’ adherence to the âsee and treatâ guidelines of the Botswana National Cervical Cancer Prevention Program. Cancer Prev Res (Phila). 2020; 13 (3): 329â36.
UNAIDS. Country sheets. https://www.unaids.org/en/regionscountries/countries/botswana.
Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR 3rd, Suneja G, Kayembe MK, et al. Cancer incidence following the expansion of HIV treatment in Botswana. PLoS ONE. 2015; 10 (8): e0135602.
Ramogola-Masire D, de Klerk R, Monare B, Ratshaa B, Friedman HM, Zetola NM. Prevention of cervical cancer in HIV infected women using the âsee and treatâ approach in Botswana. J Acquir Immune Defic Syndr. 2012; 59 (3): 308-13.
Grover S, Raesima M, Bvocora-Nsingo M, Chiyapo SP, Balang D, Tapela N, et al. Cervical cancer in Botswana: current status and future steps in screening and treatment programs. Oncol before. 2015; 5: 239.
Barchi F, Winter SC, Ketshogile FM, Ramogola-Masire D. Meeting screening appointments at a cervical cancer clinic serving HIV-positive women in Botswana. BMC Public Health. 2019; 19 (1): 318.
Jeronimo J, Castle PE, Temin S, Denny L, Gupta V, Kim JJ, et al. Secondary prevention of cervical cancer: a clinical practice guide layered on ASCO resources. J Glob Oncol. 2017; 3 (5): 635â57.
Grover S, MacDuffie EC, Wang Q, Bvocora-Nsingo M, Bhatia RK, Balang D, et al. HIV infection is not associated with initiating curative treatment in women with cervical cancer in Botswana. Cancer. 2019; 125 (10): 1645â53.
Grover S, Chiyapo SP, Puri P, Narasimhamurthy M, Gaolebale BE, Tapela N, et al. Multidisciplinary Gynecologic Oncology Clinic in Botswana: A Model of Multidisciplinary Oncology Care in Low and Middle Income Settings. J Glob Oncol. 2017; 3 (5): 666-70.
Botswana demography. https://www.statsbots.org.bw/guide-villages-botswana.
Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for cervical carcinoma. Int J Gynaecol Obstet. 2019; 145 (1): 129-35.
Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019; 393 (10167): 169-82.
Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation of missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009; 338: b2393.
White IR, Daniel R, Royston P. Avoiding perfect prediction bias in multiple imputation of incomplete categorical variables. Calculation of analytical statistical data. 2010; 54 (10): 2267â75.
White IR, Royston P, Wood AM. Multiple imputation using chained equations: problems and tips for practice. Stat Med. 2011; 30 (4): 377â99.
Sankaranarayanan R. Cancer screening in low- and middle-income countries. Ann Glob Health. 2014; 80 (5): 412-7.
Raesima MM, Forhan SE, Voetsch AC, Hewitt S, Hariri S, Wang SA, et al. Human papillomavirus vaccine coverage among schoolgirls in a demonstration project â Botswana, 2013. MMWR Morb Mortal Wkly Rep. 2015; 64 (40): 1147-9.
Castle PE, Varallo JE, Bertram MM, Ratshaa B, Kitheka M, Rammipi K. High-risk prevalence of human papillomavirus in self-collected cervicovaginal specimens from women seronegative for human immunodeficiency virus (HIV) and women living with HIV living in Botswana. PLoS ONE. 2020; 15 (2): e0229086.
Mingo AM, Panozzo CA, DiAngi YT, Smith JS, Steenhoff AP, Ramogola-Masire D, et al. Cervical cancer awareness and screening in Botswana. Int J Gynecol Cancer. 2012; 22 (4): 638â44.
Matenge TG, Mash B. Barriers to Accessing Cervical Cancer Screening Among HIV-Positive Women in Kgatleng District, Botswana: A Qualitative Study. PLoS ONE. 2018; 13 (10): e0205425.
Bhatia RK, Rayne S, Rate W, Bakwenabatsile L, Monare B, Anakwenze C, et al. Patient factors associated with delays in obtaining cancer care in Botswana. J Glob Oncol. 2018; 4: 1â13.
Wu ES, Urban RR, Krantz EM, Mugisha NM, Nakisige C, Schwartz SM, et al. The association between HIV infection and the presentation and survival of cervical cancer in Uganda. Gynecol Oncol Rep. 2020; 31: 100516.
El Ibrahimi S, Pinheiro PS. The effect of marriage on stage at diagnosis and survival in women with cervical cancer. Psychooncology. 2017; 26 (5): 704-10.
Tapera R, Moseki S, January J. The state of health promotion in Botswana. J Public Health Afr. 2018; 9 (1): 699.